Back to CVE records
Medium 6.1Published May 20, 2026

CVE-2026-26028CryptPad is an end-to-end encrypted collaborative office suite.

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

CryptPad is an end-to-end encrypted collaborative office suite. In versions prior to 2026.2.0, the HTML sanitizer in Diffmarked.js can be bypassed due to incomplete attribute filtering on restricted tags. The sanitizer validates only the src attribute of <iframe>, <video>, and <audio> elements, leaving all other attributes unchecked. As a result, an attacker can inject arbitrary HTML through srcdoc, completely defeating CryptPad's intended bounce sandboxing and enabling link injection or other interactive content within user-controlled documents. The root cause lies in how the sanitizer classifies and enforces tag restrictions: although it defines both forbidden and restricted tag lists, <iframe> is treated as "restricted" rather than "forbidden." Enforcement then inspects only the src attribute, so pairing a benign blob: src with a malicious srcdoc results in unrestricted rendering. This issue has been fixed in version 2026.2.0.

CVSS
6.1 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-79, CWE-116
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Deferred
Record last updated
Jul 23, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.